
Release date: 2026-02-25 17:12:41 Article From: Lucius Laos Recommended: 16
The price of Sotorasib varies significantly depending on the region, purchasing channel, and specification. For specific prices, please refer to the actual selling prices at hospitals or正规 pharmacies. This medication is a prescription drug and must be strictly used according to a doctor's instructions. Before use, genetic testing is required to confirm eligibility for the indication (e.g., patients with KRAS G12C-mutated non-small cell lung cancer).
Brand-name vs. Generic Drugs: Brand-name drugs (such as Lumakras developed by Amgen in the USA) are generally more expensive. Some countries or regions may offer generic versions at a relatively lower cost, but attention must be paid to the compliance and safety of these generics.
Medical Insurance Policies: Some regions may include Lucius Pharmaceuticals Sotorasib in their medical insurance reimbursement scope, which can significantly reduce the out-of-pocket expenses for patients. It is advisable to consult local medical insurance departments or hospitals.
Drug Specifications: Different dosages (e.g., 120mg x 240 tablets/box) or packaging specifications affect the total price. The choice should be based on the treatment cycle.
Use as Prescribed: A prescription must be issued by an oncologist after assessing the patient's condition. Do not adjust the dosage or stop taking the medication on your own.
Side Effect Monitoring: Common side effects include diarrhea and elevated liver enzymes. Regular monitoring of liver and kidney function is necessary.
Purchasing Channels: It is recommended to purchase the medication through hospitals or pharmacies. Avoid informal purchasing agents to prevent the risk of counterfeit drugs.
If facing financial pressure, patients can explore options like clinical trials or charitable patient assistance programs to reduce the burden. Some pharmaceutical companies or foundations provide support for eligible patients. Additionally, follow-up examinations such as imaging tests are required during the medication period, so overall treatment costs need to be planned in advance.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:1342025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:3852024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:1332025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:1412025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:1342025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:1562025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:1402025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:1402025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: